Premium
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic
Author(s) -
Schulzer M.,
Mak E.,
Calne D. B.
Publication year - 1992
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410320614
Subject(s) - transient (computer programming) , medicine , computer science , operating system
We undertook an analysis of the hazard functions derived from results published by the Parkinson Study Group following their investigation of deprenyl. Our findings indicate that the action of deprenyl is transient rather than sustained. We also infer that this effect may be mediated through alleviation of symptoms rather than by neuroprotection.